Naltrexone for reducing self-injury urges
Treatments studied
Part of Mental health clinical trials.
This trial tests a medication called naltrexone to see if it can reduce the urge to hurt yourself. If you have a strong, repeated urge to self-injure, this treatment might help you feel more in control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years old or older.
- You have hurt yourself intentionally (like cutting or burning) more than once in the last two months.
- You often feel a strong urge to hurt yourself.
- You are not currently using opioids (like heroin, morphine, or prescription pain pills).
- You do not have active liver disease, kidney disease, or severe liver problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether naltrexone, a medication that blocks opioid receptors in the brain, can reduce nonsuicidal self-injurious behavior (like cutting or burning). Researchers believe this medication may help decrease the urge to self-injure.
This trial tests a naltrexone implant designed to help people with moderate to severe alcohol use disorder cut down on drinking. The implant slowly releases medication for several months, so you don't have to remember to take a pill every day.
This Phase 4 study tests whether naltrexone injections can help people with alcohol use disorder (AUD) reduce or stop heavy drinking. You may get two injections over 8 weeks, and you can join if you meet specific drinking pattern and eligibility rules.
This trial is testing if taking cannabidiol (CBD) plus naltrexone can reduce alcohol craving in people with alcohol dependence. Naltrexone is already used to help with alcohol cravings, and CBD may add extra benefit.
This trial tests whether naltrexone, a medication that blocks the effects of opioids, can help prevent overdose in people who use stimulants like cocaine or methamphetamine. It may be a good fit if you are at risk for HIV or living with HIV, and have a stimulant use disorder or use stimulants at least 10 days per month.
This Phase 2 study tests whether low-dose naltrexone can reduce pain from vulvodynia. It also looks at how well it works across different vulvodynia types, comparing to what participants are already doing for symptoms.
Hear when a new Nonsuicidal Self Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.